Month: February 2023

A strategy for the treatment of tuberculosis (TB) involving just an 8-week treatment regimen — along with close posttreatment monitoring and treatment extension if needed — shows potential as an effective alternative to the standard 24-week regimen. “We found that if we use the strategy of a bedaquiline–linezolid five-drug regimen for 8 weeks and then
0 Comments
With one in eight of us feeling tired all the time, could sleep tourism help us feel more rested and relaxed? Or is it just another wellness trend to get us to book a new kind of vacation? As a nation, we are tired. According to YouGov, one in four of us feels tired most
0 Comments
OSLO, Norway, Feb. 20, 2023. Photocure ASA, The Bladder Cancer Company, announces the presentation of clinical data from the Veterans Affairs (VA) BRAVO study at the ASCO Genitourinary Cancers Symposium (ASCO GU) which was held February 16-18, 2023 in San Francisco, USA. The clinical data demonstrated a significant decrease in the risk of recurrence &
0 Comments
For parents, the decision to vaccinate their kids against SARS-CoV-2 is complex, influenced by scientific evidence, political and social pressures, and views about individual versus collective benefits of vaccination, according to a new study published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221401. Researchers conducted a qualitative study with in-depth interviews of 20 parents to understand
0 Comments
In this article BIIB ESALY 4523.T-JP Follow your favorite stocksCREATE FREE ACCOUNT Tek Image/science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer, which would expand access to the pricey new antibody under Medicare. U.S. CEO Ivan
0 Comments
SAN FRANCISCO — First-line nivolumab (Opdivo) plus cabozantinib (Cabometyx) continued to demonstrate clinically meaningful survival benefits in advanced renal cell carcinoma (RCC). An update of the CheckMate 9ER trial, which compared the immune checkpoint inhibitor/tyrosine kinase inhibitor (TKI) doublet with the TKI sunitinib (Sutent), showed that after 44 months of median follow-up, median progression-free survival
0 Comments
FDA Approves Syfovre (pegcetacoplan injection) for the Treatment of Geographic Atrophy, a Leading Cause of Blindness WALTHAM, Mass., Feb. 17, 2023 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that the U.S. Food and Drug Administration (FDA) has approved Syfovre™ (pegcetacoplan injection) for the treatment
0 Comments
HMX Immunology instructors Shiv Pillai and Andrew Lichtman explain why you need to know immunology – and what makes it so exciting. Learn more about this online course from Harvard Medical School: http://bit.ly/hmximmu HMX courses cover fundamental medical concepts through detailed visualizations, real-world scenarios, and genuine patient interactions. Courses are appropriate for those considering or
0 Comments
Administrative Assistants collaborate with a variety of Mayo Clinic leaders such as providers, administrators, scientists, and many other members of the team. Their work consists of a variety of tasks such as meeting arrangements, travel planning, research support, and project assistance. Innovation, organization, and communication skills are vital to the success of Mayo Clinic’s Administrative Assistants.
0 Comments
SAN FRANCISCO — New findings lend further support to adjuvant nivolumab (Opdivo) as a standard of care for patients with metastatic urothelial cancer. Extended follow-up data from the phase 3 CheckMate 274 trial continue to show that, compared with placebo, nivolumab improves disease-free survival, non-urothelial tract recurrence-free survival (NUTRFS), and distant metastasis-free survival (DMFS) in
0 Comments
Scientists are reportedly developing a “smart necklace” that has the potential to help smokers quit cigarettes. The monitoring device, which is being developed by researchers at the Northwestern University in the U.S., is called SmokeMon.  The study on the promising new device was published in the journal Proceedings of the ACM on Interactive, Mobile, Wearable, and Ubiquitous Technologies.
0 Comments
Editor’s Note: Sign up for CNN’s Stress, But Less newsletter. Our six-part mindfulness guide will inform and inspire you to reduce stress while learning how to harness it. CNN  —  For many parents, the “Is it normal?” game begins early on. I’ve sent question after question to family and friends, and of course, all worried
0 Comments
BEIJING (Reuters) – China’s top leaders declared a “decisive victory” over COVID-19, claiming the world’s lowest fatality rate, although experts have questioned Beijing’s data as the coronovirus tore across the country after largely being kept at bay for three years. China abruptly ended its zero-COVID policy in early December, with 80% of its 1.4 billion
0 Comments
Scientists recently discovered a new species of mosquito that could spread malaria faster in Kenya.  The species, named Anopheles stephensi, was reportedly discovered by a team of researchers at Kenya Medical Research Institute (Kemri), alongside the Ministry of Health’s Division of National Malaria Program (DNMP), according to the Kenyan newspaper The Standard.  Kemri scientists first
0 Comments
In a recent study published in the Lancet, researchers performed a systematic review of scientific literature published from inception up to September 31, 2022, that documented the reduction in risk of coronavirus disease 2019 (COVID-19) among individuals with a prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection vis-à-vis those with no COVID-19 history. They
0 Comments
By sifting through electronic health records of moms and babies using a machine-learning algorithm, scientists can predict how at-risk newborns will fare in their first two months of life. The new method allows physicians to classify, at or before birth, which infants are likely to develop complications of prematurity. A study describing the method, developed
0 Comments
Sen. Susan Collins (R-ME) speaks to reporters in the Senate Subway during a vote in the U.S. Capitol on September 08, 2022 in Washington, DC. Anna Moneymaker | Getty Images U.S. senators on Friday called for Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that current restrictions
0 Comments
TOKYO, Feb. 19, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., “Astellas”) today announced the U.S. Food and Drug Administration (FDA) notified the company that it is extending the original priority review Prescription Drug User Fee Act (PDUFA) goal date for fezolinetant, an investigational agent for the treatment of
0 Comments
New once-daily Austedo XR regimen now approved in 6, 12, and 24 mg tablet strengths Austedo is the only vesicular monoamine transporter 2 (VMAT2) inhibitor approved for both tardive dyskinesia (TD) and chorea associated with Huntington’s disease (HD) indications1,2 Austedo is the only VMAT2 inhibitor with 3-year long-term data for both TD and HD chorea1,2
0 Comments
On June 14, 2017, just before noon, a doctor made an incision near a patient’s groin. Kari Kirk, a representative for the world’s largest medical device company, Medtronic, looked on and began texting her colleague a play-by-play. “Fixing both legs from the ankles,” she wrote. It was a fairly common procedure at the Robert J.
0 Comments
Sign up for CNN’s Wonder Theory science newsletter. Explore the universe with news on fascinating discoveries, scientific advancements and more. CNN  —  A trio of telescopes captured a new view of the sun that reveals the star’s invisible light. Humans can see optical or visible light, but many wavelengths of light remain hidden from our
0 Comments